Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Lipitor Legal News Articles & Interviews

View Lawyer Interviews only

Beyond Lipitor Type 2 Diabetes, a New Concern with Statins

Beyond Lipitor Type 2 Diabetes, a New Concern with Statins September 19, 2015. By Gordon Gibb.
Bangor, ME Among the ongoing concerns over the statin Lipitor are the potential for type 2 diabetes and cognitive issues such as memory and concentration. Atorvastatin (Lipitor) type 2 diabetes remains one of the biggest frustrations alleged in lawsuits consolidated in the Lipitor Diabetes Lawsuits MDL. Various plaintiffs have alleged that for them, type 2 diabetes appeared to come out of nowhere with no corresponding family history or risk factors for diabetes.
Read [ Beyond Lipitor Type 2 Diabetes, a New Concern with Statins ]

Number of Diabetes Lawsuits in Lipitor MDL above 2,200 and Climbing

Number of Diabetes Lawsuits in Lipitor MDL above 2,200 and Climbing June 27, 2015. By Gordon Gibb.
Washington, DC The number of cases in the Lipitor Diabetes Lawsuits MDL has climbed to more than 2,200 and with little wonder: plaintiffs maintain that prior to a label change mandated by the US Food and Drug Administration (FDA) in 2012, few, if any, had little clue that atorvastatin (Lipitor) could trigger type 2 diabetes.
Read [ Number of Diabetes Lawsuits in Lipitor MDL above 2,200 and Climbing ]

Pfizer Wins Lipitor Lawsuit in Australia

Pfizer Wins Lipitor Lawsuit in Australia March 20, 2015. By Heidi Turner.
Melbourne, Australia Pfizer may have lost its motion to dismiss in Lipitor lawsuits in the US, but the drugmaker is celebrating a victory in Australia. An Australian consumer watchdog filed a Lipitor lawsuit against Pfizer, alleging the company engaged in anticompetitive practices linked to its sales of generic Lipitor.
Read [ Pfizer Wins Lipitor Lawsuit in Australia ]

Pfizer’s Attempt to Toss Lawsuits in Lipitor Diabetes Lawsuits MDL Rejected

Pfizer’s Attempt to Toss Lawsuits in Lipitor Diabetes Lawsuits MDL Rejected February 5, 2015. By Gordon Gibb.
Charleston, SC The manufacturer of Lipitor recently attempted to cast off 10 atorvastatin type 2 diabetes cases in the Lipitor Diabetes Lawsuits MDL on grounds that failure-to-warn claims made by the plaintiffs were preempted by federal regulation.
Read [ Pfizer’s Attempt to Toss Lawsuits in Lipitor Diabetes Lawsuits MDL Rejected ]

Consolidated Lipitor Lawsuits Sit At More Than 1,600

Consolidated Lipitor Lawsuits Sit At More Than 1,600 January 19, 2015. By Heidi Turner.
Charleston, SC The number of consolidated Lipitor lawsuits continues to grow and now sits at more than 1,600, according to court documents. Those lawsuits allege that women were not properly warned about the risk of Lipitor side effects, including a reported increased risk of diabetes.
Read [ Consolidated Lipitor Lawsuits Sit At More Than 1,600 ]

Lipitor Lawsuits Climbing but Pfizer Digging In

Lipitor Lawsuits Climbing but Pfizer Digging In December 19, 2014. By Gordon Gibb.
New York, NY As the number of cases in the Lipitor Diabetes Lawsuits MDL continue to spike, Lipitor manufacturer Pfizer Inc. continues to position itself following the expiration of its patent in November 2011. One of those moves, as evidenced by a Bloomberg report earlier this year, is a hoped-for introduction of an over-the-counter (OTC) version of Lipitor (atorvastatin) at some point in the near future.
Read [ Lipitor Lawsuits Climbing but Pfizer Digging In ]

Lipitor Litigation Moves Forward

Lipitor Litigation Moves Forward November 19, 2014. By Heidi Turner.
Charleston, SC Lipitor multidistrict litigation, alleging patients suffered Lipitor side effects and developed diabetes as a result of taking the medication, continue to move forward with regular status conferences. Three more Lipitor lawsuits have been dismissed due to failure to provide required documentation. Among the required documentation that has not been provided is a Plaintiff Fact Sheet and a response to Pfizer’s motion to dismiss.
Read [ Lipitor Litigation Moves Forward ]

Twenty Lipitor Lawsuit Claims Dismissed

Twenty Lipitor Lawsuit Claims Dismissed October 16, 2014. By Heidi Turner.
Charleston, SC Twenty Lipitor lawsuits involved in Lipitor multidistrict litigation have been dismissed from the court for failure to provide required documentation. The lawsuits alleged that plaintiffs suffered from Lipitor side effects as a result of taking the medication.
Read [ Twenty Lipitor Lawsuit Claims Dismissed ]

Lipitor Lawsuits Growing, but Concern Extends beyond Atorvastatin Type 2 Diabetes

Lipitor Lawsuits Growing, but Concern Extends beyond Atorvastatin Type 2 Diabetes September 24, 2014. By Gordon Gibb.
Washington, DC It is no secret that Lipitor diabetes lawsuits have been growing exponentially, with more than 200 lawsuits recently added to the Lipitor diabetes lawsuits MDL in South Carolina (In re Lipitor (atorvastatin) Litigation, MDL No. 2502, US District Court, District of South Carolina). According to PRWeb Newswire (9/1/14), the litigation count was at 1,162 at the beginning of the month. Given the rapid rise in cases, it is presumed that number is higher still as of this writing.
Read [ Lipitor Lawsuits Growing, but Concern Extends beyond Atorvastatin Type 2 Diabetes ]

Following Suit: Lipitor Lawsuit Updates

Following Suit: Lipitor Lawsuit Updates September 3, 2014. By Jane Mundy.
Philadelphia, PA By August 15, 2014, court records show that 1,162 Lipitor claims have been filed against Pfizer Inc., the manufacturer of the “best-selling prescription drug of all time.” The Lipitor lawsuits filed by plaintiffs who developed Type 2 diabetes allege that Pfizer failed to adequately warn patients and their doctors about the cholesterol medication’s association with diabetes and other risks associated with Lipitor.
Read [ Following Suit: Lipitor Lawsuit Updates ]


Request Legal Help Now! - Free